A study on the immunogenicity and safety of 3 different dose concentrations of a respiratory syncytial virus vaccine in infants and toddlers

Trial Identifier: VAD00015
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: November 2024
Primary Completion Date: June 2025
Study Completion Date: June 2025
Condition: Respiratory Syncytial Virus Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
DOMINICAN REPUBLIC SANTO DOMINGO, DOMINICAN REPUBLIC, 10201
HONDURAS SAN PEDRO SULA, HONDURAS, NULL
HONDURAS TEGUCIGALPA, HONDURAS, 11101